Abstract Reaction of NaAuCl 4 ·H 2 O and thiodiglycol (1:3 molar ratio) with 3-(aryl)-2-sulfanylpropenoic acids, C NMR spectroscopy. The antimicrobial activities of the complexes against Escherichia coli, Staphylococcus aureus, Bacillus subtilis, Candida albicans, Pseudomonas aeruginosa and carbapenem-resistant P. aeruginosa were evaluated and compared to those of the equivalent silver(I) complexes. The comparison shows that the gold compounds generally show better activity than the silver analogues against S. aureus and B. subtilis, but low sensitivity against E. coli, P. aeruginosa and C. albicans, suggesting a different mode of antimicrobial action for equivalent silver and gold compounds.
Introduction
Silver(I) and gold(I) compounds present a variety of biological activities and have various medicinal uses, the study of which has increased in recent years. Silver compounds have mainly been studied for their widely known antibacterial effect; in fact, silver nitrate and certain silver complexes are still used against local infections [1] [2] [3] . From this perspective, compounds with Ag kernels have recently been prepared and studied, including examples containing Ag-N [4] [5] [6] [7] , Ag-O [8] [9] [10] and Ag-S [11] [12] [13] [14] [15] bonds and some with other additional bonds. In previous papers, we have contributed [14, 15] to the study of Ag-S by preparing compounds of the type [Ag (HL)], [Ag 2 
(L)], [HQ][Ag(L)] (HQ0diisopropylammonium)
and Na[Ag(L)]·xH 2 O, where H 2 L is a 3-(aryl)-2-sulfanylpropenoic acid or 2-cyclopentylidene-2-sulfanylacetic acid, which can be present as a mono-or bideprotonated system in the complexes. The last two classes of compounds, especially the latter, show activity against certain Gram-positive and Gramnegative bacteria, and also against the yeast Candida albicans; this activity is similar to that shown by other compounds with Ag-N and/or Ag-O bonds except in the case of Escherichia coli, for which they show only low activity.
Studies on gold complexes have mainly focused on antiarthritic properties [16] [17] [18] [19] [20] [21] , but growing interest is evident in antitumoral [22] [23] [24] , antiparasitic [25] and antibacterial activities. In this last field, the compounds under investigation include a major collection of the type R 3 PAuL, in which the gold atom is coordinated to a phosphine ligand and L is an O- [26, 27] , N- [28, 29] , Cl- [30] or S- [29, [31] [32] [33] [34] [35] 2 ], Na 3 [Au(mna) 2 ] (H 2 mna 02-mercaptonicotinic acid) [13] and the cationic complexes [Au(L) 2 ](NO 3 ) 3 (L01-[2-(acridin-9-ylamino)ethyl]-1,3-dimethylthiourea) [34] . For the latter ligand, compounds of the type [Au(L)]Br, [Au(L)] SCN and [Au(L)]Cl were also prepared [34] and the coexistence of an S-donor ligand and a Cl ligand was also described for [LAuCl] (where L 02,3-diphenyl-1,3,4-thiadiazolium-5-thiolato-S exo ) [36] .
The activity of some of these complexes is significant against some bacteria or mycobacteria; however, there is a limited number of gold(I) complexes of this class that have been studied and a broad comparative study with equivalent silver(I) complexes having similar ligand/metal stoichiometry has not been carried out.
As mentioned above, we have previously prepared [14, 15] several silver(I) complexes containing a variety of sulfanylcarboxylate ligands, thus enabling the aforementioned comparative study. In order to carry out this comparison, we have prepared and characterised equivalent gold(I) complexes of the type [Au(HL)], [HQ] [Au(L)] (HQ0diisopro-pylammonium) and Na[Au(L)]·H 2 O. The activities of these complexes were determined and analysed in light of the results obtained for the equivalent silver(I) complexes.
Experimental

Materials and methods
The 3-(aryl)-2-sulfanylpropenoic acids (Scheme 1) were prepared by condensation of the appropriate aldehyde with rhodanine, subsequent hydrolysis in an alkaline medium and acidification with aqueous HCl. In the preparation of 2-cyclopentylidene-2-sulfanylacetic acid, a ketone (cyclopentanone) was used in the condensation reaction instead of an aldehyde [14, 15, 37] . NaAuCl 4 ·2H 2 O (Aldrich), S (CH 2 CH 2 OH) 2 (Aldrich), diisopropylamine (Merck) and NaOH (Probus) were all used as supplied.
Elemental analyses were performed on a Fisons 1108 microanalyser. Melting points were determined with a Büchi apparatus. IR spectra (KBr pellets or Nujol mulls) were recorded on a Bruker IFS66V FT-IR spectrophotometer and are reported in the synthesis section using the following abbreviations: vs0very strong, s0strong, m0medium, w0 weak, sh0shoulder, br0broad.
1 H, 13 C and DEPT NMR spectra in solution were recorded in dimethyl sulfoxide (DMSO)-d 6 at room temperature on a Bruker AMX 300 spectrometer operating at 300. H NMR spectra are defined as s0 singlet, d0doublet, t0triplet, m0multiplet, pst0pseudotriplet and br0broad. The numbering scheme is shown in Scheme 1.
Antimicrobial activity
Antibacterial activity was initially assayed by Müller-Hinton agar diffusion methods. Compounds 1-11 were suspended in water containing 0.1% of DMSO, the ligands and compounds 12-22 were dissolved in ethanol and compounds 23-33 were dissolved in water. Paper discs (5 mm in diameter) were impregnated with 20 μL of a 2 mg/cm 3 solution or suspension of the substance to be tested and control discs were impregnated with solvent alone. The discs were then placed on dishes of Müller-Hinton agar inoculated with Staphylococcus aureus (ATCC29213), Bacillus subtilis (ATCC6633), Escherichia coli (ATCC25922), Pseudomonas aeruginosa (ATCC27853) and a carbapenemresistant strain of P. aeruginosa (hereafter "resistant P. aeruginosa"). After incubation for 24 h at 37°C, the diameters of the bacterial growth inhibition zones were measured. All assays were carried out in duplicate. For products that showed activity, serial dilutions in Müller-Hinton broth were used as described in the literature [38] to determine the minimum inhibitory concentration (MIC), which is defined as the lowest concentration of the substance under test that inhibits the visible growth of the test organism when the latter is at optimal concentration. Minimum bactericidal concentration (MCB) was also determined for active compounds. Briefly, after MIC determination (24 h of exposure to compounds) bacterial cultures were subcultured in plates of solid medium without test compounds and incubated for 24 h. MCB was defined as the lowest concentration able to prevent bacterial growth in the first 24 h after compound removal.
Synthesis
Complexes of the type [Au(HL)] Complexes 1-11 were prepared by adding a stirred solution of NaAuCl 4 ·H 2 O and S (CH 2 CH 2 OH) 2 (thiodiglycol) in a 1:3 molar ratio in water to a solution of the appropriate sulfanylcarboxylic acid (metal/ ligand molar ratio 1:1) in ethanol. The mixture was stirred at room temperature for 1 h and the resulting solid was filtered off, washed with ethanol, water and ether and dried in vacuo.
[Au(Hpspa)] (1 (7) [ 
Results and discussion
Synthesis and characterization
Complexes were prepared as described in the "Experimental" The IR spectra of [Au(HL)] complexes do not show the ν(SH) band present at around 2,550 cm −1 in the spectra of the free ligands. Furthermore, the vibrations of the COOH group are slightly shifted from their positions in the spectra of the free ligands [14, 15] . These features suggest that, as in other complexes in which the COOH group is present, this group is not deprotonated and remains uncoordinated, with the complexes probably being polymeric species supported by Au-S bonds, as previously suggested for equivalent silver complexes [14, 15, 39, 40] . In the case of [HQ][Au(L)], the common features for the complexes are the absence of the ν(SH) band and of the bands due to the COOH group; both of these observations are consistent with the bideprotonation of the ligand in all cases. The existence of the diisopropylammonium cation is confirmed by the presence, at around 1,600 cm −1 , of a band due to the NH 2 + group [41] , which was previously identified in equivalent complexes with the same ligands [14, 15] . The ν asym (CO 2 − ) and ν sym (CO 2 − ) bands are located in similar positions in the spectra of all the complexes, suggesting the same coordination mode for the carboxylate group, which, in all cases, acts as a monodentate group that is hydrogen bonded to the HQ cations [14, 15, 42] The IR spectra of Na[Au(L)]·H 2 O complexes do not contain the ν(SH) band or the bands due to the COOH group. The positions of the ν asym (CO 2 − ) and ν sym (CO 2 − ) bands are again similar in all of the complexes and these positions are again compatible with the same kind of monodentate coordination mode for the carboxylate group, which, in these cases, can be hydrogen bonded to the H 2 O molecule instead of the diisopropylammonium cation.
NMR studies
For complexes of the type [Au (HL)] (1-11) , the broad signal at around 13 ppm in the 1 H NMR spectra of the ligands persists, an observation consistent with the presence of the protonated COOH group. This signal is not present in the spectrum of the [Au(H-o-pyspa)] complex, probably due to an interchange with the deuterium of the solvent. In the 1 H spectrum of H 2 -o-pyspa the presence of a broad singlet at 17.85 ppm is consistent with protonation of the pyridine nitrogen, which, together with the presence of only one proton on C(3)H, suggests that this compound is in the thione form in solution and not in the enethiol form. Coordination to gold causes significant changes in the 1 H NMR spectrum; the signal attributed to N-H does not appear for the complex, a fact that reflects deprotonation of this group and the evolution of the ligand to the thiol form. The 13 C NMR spectra of these complexes show the C(3) signal shifted to higher field with respect to that in the free ligand [14, 15] , suggesting that the S-coordination found in the solid state, as in other complexes with these ligands [43, 44] , is retained in solution.
For 1 H NMR spectra show a shift in the ligand C (3)H signal to higher field on complexation, which again suggests the persistence of the S-Au bond in solution; the disappearance of the broad signal located at around 13 ppm in the spectra of each free acid evidences the deprotonation of the COOH group in the complexes. The persistence of the S-coordination was confirmed by the shift in the C(3) signal in the 13 C NMR spectra. In these spectra, the C(1) peaks are in positions close to those found in compounds with a coordinated carboxylate group [45, 46] and, in particular, in the equivalent silver complexes [14, 15] .
Antimicrobial activity
Antibacterial and antifungal activities are listed in Tables 1  and 2 , as estimated by minimum inhibitory concentration (MIC; microgrammes per millilitre) and minimum bactericidal concentration (MBC; microgrammes per millilitre). Remarkable activity was not exhibited by either diisopropylammonium chloride [42] , the ligands or complexes of the type [Au(HL)] (1-11), which in the case of the complexes can be attributed to the low solubility.
The majority of these new complexes showed better activity against the Gram (+) bacteria S. aureus and B. subtilis than against the Gram (−) E. coli and P. aeruginosa (the lower activity is shown against this latter bacterium even though the values are similar to those for E. coli). However, there are differences between the two classes of compounds and also between the compounds included in the [ (32) showed good values against the two Gram (+) bacteria and E. coli.
In an attempt to assess the bactericidal or bacteriostatic activity of these compounds, we also determined the MBC values for most of the synthesised compounds (Table 2 ). In the range of concentrations studied, we found bactericidal activity for some complexes and, as can be seen in Table 2 , this activity is particularly relevant against E. coli and B. subtilis.
In O (33) , all of the complexes showed bactericidal activity-albeit at higher concentrations than those at which bacteriostatic activity was observed. In any case, none of the microorganisms tested showed tolerance to these products because the MIC/MBC ratio was less than 32 in all cases.
Only three compounds showed bactericidal activity against S. aureus, and these were [ Table 3 enable a comparison of the activity between silver and gold complexes that incorporate the same ligand. It is interesting to underline the better activity of some gold compounds against E. coli, a Gram(−) bacterium that shows a low sensitivity to the previously prepared silver complexes.
The behaviour outlined above, with some exceptions-in particular for the Na derivatives-was also observed against the two Gram(+) bacteria but it did not persist against P. aeruginosa and the carbapenem-resistant P. aeruginosa. In these cases, the silver complexes generally showed better values than the gold complexes, as also shown against C. albicans.
If we consider the HQ and Na derivatives together and analyse the effect of the introduction of Au instead of Ag while maintaining the same ligand, the most marked effect was observed for -o-hpspa and diBr-o-hpspa, both ligands for which the phenyl group on the C(3) of the sulfanylpropenoic acid contains an -OH substituent in the ortho position.
Different activities were also previously found for equivalent Ag and Au complexes with P-donor [28] , S-donor [13] or N-donor ligands [47] . As an interesting example in the latter case, it was shown [47] that [1-benzyl-3-tert-butylimidazol-2-ylidene]AuCl has significant activity against B. subtilis and that this activity is higher than that of the equivalent silver complex. Incubation of B. subtilis cells with the gold complex increased the cell length, indicating that this compound inhibits bacterial proliferation by blocking cytokinesis. In contrast, only a very small increase in cell length was observed under equivalent incubation with the silver complex. A different mode of antimicrobial action for equivalent silver and gold complexes was also previously proposed by Nomiya et al. [13, 28] . and Na[Au(L)]·H 2 O show significant activity against the Gram(+) bacteria S. aureus and B. subtilis. The gold compounds generally show better activity than the silver analogues against S. aureus and B. subtilis, but low sensitivity against E. coli, P. aeruginosa and C. albicans. The results suggest a different mode of antimicrobial action for equivalent silver and gold compounds.
Conclusion
